Current role of device therapy to reduce sudden cardiac death in heart failure

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Research

Background:

• Sudden cardiac death (SCD) is a significant cause of mortality in heart failure (HF) patients.
• Despite medical advancements, HF mortality, particularly from SCD, remains a critical concern.

Purpose of the Study:

• To review the role of device therapy in reducing SCD in HF patients.
• To discuss the clinical benefits of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT).

Main Methods:

• Review of pertinent clinical trial data on device therapy in HF.
• Analysis of the impact of ICD and CRT on HF mortality.

Main Results:

• Clinical trials support the prophylactic use of ICDs in specific HF populations.
• CRT has established clinical benefits in advanced HF.
• The Comparison of Medical Therapy Pacing and Defibrillation in Heart Failure trial demonstrated survival benefits with CRT, alone or with ICD.

Conclusions:

• Device therapy, including ICD and CRT, is vital in reducing SCD and mortality in HF.
• Future challenges for device manufacturers and clinicians in HF management need addressing.